推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Evidence-based Complementary and Alternative Medicine

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 EVID-BASED COMP最新评论:被踢出sci了吗?pubmed上还显示影响因子,哪里能查到? (2023-06-02)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Evidence-based Complementary and Alternative Medicine期刊基本信息Hello,您是该期刊的第277487位访客

基本信息 登录收藏
期刊名字Evidence-based Complementary and Alternative MedicineEvidence-based Complementary and Alternative Medicine

EVID-BASED COMPL ALT
(此期刊未被最新的JCR期刊引证报告收录)

LetPub评分
5.8
70人评分
我要评分

声誉
6.1

影响力
4.7

速度
8.6

期刊ISSN1741-427X
微信扫码收藏此期刊
E-ISSN1741-4288
2022-2023最新影响因子
(数据来源于搜索引擎)
0 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:1.849
2022-2023自引率N.A.点击查看自引率趋势图
五年影响因子0
h-index 72
CiteScore
CiteScoreSJRSNIPCiteScore排名
3.500.4690.802
学科分区排名百分位
大类:Medicine
小类:Complementary and Alternative Medicine
Q232 / 97

期刊简介
Evidence-Based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine.

The journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. The journal does not consider articles on homeopathy.
期刊官方网站https://www.hindawi.com/journals/ecam
期刊投稿网址http://mts.hindawi.com/login/
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Evidence-based Complementary and Alternative Medicine的语言要求,还能让Evidence-based Complementary and Alternative Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Evidence-based Complementary and Alternative Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2400; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:alternative medicine、complementary therapies
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP
出版商Hindawi Publishing Corporation
涉及的研究方向医学-全科医学与补充医学
出版国家或地区ENGLAND
出版语言English
出版周期Quarterly
出版年份2004
年文章数 1405点击查看年文章数趋势图
Gold OA文章占比98.70%
研究类文章占比:
文章 ÷(文章 + 综述)
83.06%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:0区

暂无按学科分区信息
中科院《国际期刊预警
名单(试行)》名单
预警提示:2023年3月20日剔除出SCIE目录

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
(没有被最新的JCR升级版收录,仅供参考)
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
INTEGRATIVE & COMPLEMENTARY MEDICINE
全科医学与补充医学
3区1区4区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区1区
INTEGRATIVE & COMPLEMENTARY MEDICINE
全科医学与补充医学
1区2区4区
SCI期刊收录coverage 预警提示:2023年3月20日剔除出SCIE目录

Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1741-427X%5BISSN%5D
平均审稿速度网友分享经验:
平均2.2月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Evidence-based Complementary and Alternative Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Evidence-based Complementary and Alternative Medicine期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Evidence-based Complementary and Alternative Medicine中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Evidence-based Complementary and Alternative Medicine上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    AMERICAN JOURNAL OF CHINESE MEDICINE559.30
    JOURNAL OF ETHNOPHARMACOLOGY1708.60
    COMPLEMENTARY THERAPIES IN MEDICINE557.20
    Chinese Journal of Integrative Medicine285.30
    INTEGRATIVE CANCER THERAPIES535.30
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE804.00
    Explore-The Journal of Science and Healing32.70
    Homeopathy353.00
    ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH240.50
    African Journal of Traditional Complementary and Alternative Medicines00.00
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    此期刊未被最新的JCR收录
  •  

    Evidence-based Complementary and Alternative Medicine Evidence-based Complementary and Alternative Medicine
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics

    Author: Zhang, Rui; Lu, Zhe; Xu, Yachen; Peng, Qian; Xiao, Man; Sang, Shenggang
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5625222
        PubMed      DOI
    2.Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition

    Author: Tang, Ling; Yu, Xiao; Zou, Lu; Li, Shaobin; Cheng, Yanqi; Wu, Yuqin; Xing, Lianjun; Fang, Hong
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5642713
        PubMed      DOI
    3.Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma

    Author: Jia, Wenqing; Xu, Chengling; Zhao, Tong; Fan, Qiuyang; Qiao, Bo; Wu, Yueying; Yuan, Jiali; Chen, Jing
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1130893
        PubMed      DOI
    4.Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease

    Author: Chen, Yulian; Song, Xiaodan; Luo, Yunxia; Li, Guandong; Luo, Yueming; Wang, Ziyan; He, Riming; Lu, Jiandong; Xiong, Guoliang; Cheng, Hong; Li, Huilin; Yang, Shudong
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9208017
        PubMed      DOI
    5.beta-Sitosterol Suppresses LPS-Induced Cytokine Production in Human Umbilical Vein Endothelial Cells via MAPKs and NF-kappa B Signaling Pathway

    Author: Bi, Yiming; Liang, Hongfeng; Han, Xin; Li, Kongzheng; Zhang, Wei; Lai, Yigui; Wang, Qiang; Jiang, Xuefeng; Zhao, Xiaoshan; Fan, Huijie
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9241090
        PubMed      DOI
    6.Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation

    Author: Shou, Di-Wen; Li, Yi-Rong; Xu, Xiu-Juan; Dai, Mu-Hua; Zhang, Wei; Yang, Xue; Tu, Yue-Xing
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/8759766
        PubMed      DOI
    7.Effects of a Macroporous Resin Extract of Dendrobium officinale Leaves in Rats with Hyperuricemia Induced by Anthropomorphic Unhealthy Lifestyle

    Author: Li, Lin-Zi; Wang, Xi-Ming; Feng, Xiao-Jie; Liu, Kun; Li, Bo; Zhu, Li-Jie; Xu, Wan-Feng; Zheng, Xiang; Dong, Ying-Jie; He, Xing-Lishang; Guan, Hao-Ru; Ding, Yan-Yan; Wu, Han-Song; Zhou, Chuan-Jie; Ye, Sen-Yu; Zhang, Bei-Bei; Lv, Gui-Yuan; Chen, Su-Hong
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9990843
        PubMed      DOI
    8.Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer

    Author: Wu, Hongyan; Zhang, Lihu; Wang, Chuntao; Li, Fang; Qi, Liang; Xiao, Linxia; Zhang, Mingguang; Zhang, Hu; Zhang, Guozhe; Qin, Yiyu
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1416841
        PubMed      DOI
    9.A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification

    Author: Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei; Lin, Lizhu
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/3436814
        PubMed      DOI
    10.Rhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP-1c/FAS/ACC Signaling Pathways

    Author: Gong, Zhiqiang; Han, Sha; Li, Chenlin; Meng, Tianxiu; Huo, Yu; Liu, Xianfu; Huang, Yanhong; Yang, Lifang
    Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/6603522
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录
    同分区等级的其他期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共1885条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451